Approval · Notice of Compliance 7876 · 2006
LANTUS: Notice of Compliance 7876
Issued April 10, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7876
- Date
- April 10, 2006
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New administration scheme
- Therapeutic class
- Antidiabetic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LANTUS | Not yet assigned | — |
Medicinal ingredients
- INSULIN GLARGINE 100 UNIT per ML